関連する実験動画
Updated: May 13, 2026

10:05
High-throughput Detection Method for Influenza Virus
Published on: February 4, 2012
26.7K
Pathological and molecular characterization of infectious bronchitis virus in Kerala
B Sruthy Chandran1, Surya Sankar1, V Niranjana1
11Department of Veterinary Microbiology College of Veterinary and Animal Sciences Thrissur , Kerala Veterinary and Animal Sciences University , Kerala Wayannad, India.
Virusdisease
|December 22, 2025
まとめ
Infectious bronchitis virus (IBV) causes significant poultry losses. This study reveals high genetic diversity among IBV strains in Kerala, India, necessitating tailored vaccination strategies for effective control.
科学分野:
- 獣医ウイルス学
- 家禽病理学
- 分子疫学
背景:
- 伝染性気管支炎ウイルス(IBV)は、その多様な株とワクチンの有効性への影響により、世界的に家禽生産にとって脅威となっている。
- ケララ州におけるIBVの制御は、一貫性のないワクチン接種と疾病の蔓延により困難である。
研究 の 目的:
- ケララ州、インドのIBV分離株を特徴づけること。
- 循環しているIBV株の遺伝的多様性と病理学的影響を評価すること。
- 地域の疾病管理戦略に情報を提供すること。
主な方法:
- S1サブユニットの超可変領域3を標的とするRT-PCRを用いた80のフィールドサンプルのスクリーニング。
- 胚入り卵でのウイルス分離とRT-PCRによる確認。
- 系統発生解析のためのS1、M、N遺伝子のシーケンシング。
- 影響を受けた臓器の組織病理学的検査。
主要な成果:
- IBVが80サンプル中32サンプルから検出された。
- 系統発生解析により、ケララ州の分離株がインドの他の株と共にクラスターを形成することが示された。
- 組織病理学検査により、特徴的な病変が明らかになり、組織親和性を示唆した。
結論:
- ケララ州のIBV株間には、著しい遺伝的変異が存在する。
- 現在のワクチン接種戦略は、地域的な適応が必要となる可能性がある。
- 家禽におけるIBVの効果的な制御には、地域特異的なワクチン接種アプローチが不可欠である。
関連する概念動画
Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

